Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Khot

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|January 23, 2019
Where do we currently stand with T-cell prolymphocytic leukemia?Amit Khot
Blood|March 17, 2023
Del(1p32): prime time in (ultra) high-risk myelomaAmit Khot
Expert Review of Anticancer Therapy|March 12, 2009
T-cell prolymphocytic leukemiaAmit Khot, Claire Dearden
Leukemia & Lymphoma|January 29, 2021
"RT or not RT?" The question for early-stage peripheral T-cell lymphomaBelinda A Campbell, Amit Khot
Blood|January 7, 2012
M(yeloma)IXing up T maintenanceSimon J Harrison, Amit Khot
Chemotherapy|November 23, 2012
Acute kidney injury requiring dialysis following carmustine and etoposide during autologous stem cell transplantationJane Li, Amit Khot, Kate Burbury
Leukemia & Lymphoma|September 6, 2023
Lenalidomide maintenance in Myeloma - a goldilocks problem?Melissa Ng Liet Hing, Amit Khot
Future Oncology (London, England)|December 4, 2013
Romidepsin for cutaneous T-cell lymphomaH Miles Prince, Michael Dickinson, Amit Khot
Expert Opinion on Investigational Drugs|July 6, 2013
Panobinostat in lymphoid and myeloid malignanciesAmit Khot, Michael Dickinson, H Miles Prince
Expert Review of Hematology|September 3, 2013
Romidepsin for peripheral T-cell lymphomaAmit Khot, Michael Dickinson, H Miles Prince
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|January 23, 2019
Where do we currently stand with T-cell prolymphocytic leukemia?Amit Khot
Blood|March 17, 2023
Del(1p32): prime time in (ultra) high-risk myelomaAmit Khot
Expert Review of Anticancer Therapy|March 12, 2009
T-cell prolymphocytic leukemiaAmit Khot, Claire Dearden
Leukemia & Lymphoma|January 29, 2021
"RT or not RT?" The question for early-stage peripheral T-cell lymphomaBelinda A Campbell, Amit Khot
Blood|January 7, 2012
M(yeloma)IXing up T maintenanceSimon J Harrison, Amit Khot
Chemotherapy|November 23, 2012
Acute kidney injury requiring dialysis following carmustine and etoposide during autologous stem cell transplantationJane Li, Amit Khot, Kate Burbury
Leukemia & Lymphoma|September 6, 2023
Lenalidomide maintenance in Myeloma - a goldilocks problem?Melissa Ng Liet Hing, Amit Khot
Future Oncology (London, England)|December 4, 2013
Romidepsin for cutaneous T-cell lymphomaH Miles Prince, Michael Dickinson, Amit Khot
Expert Opinion on Investigational Drugs|July 6, 2013
Panobinostat in lymphoid and myeloid malignanciesAmit Khot, Michael Dickinson, H Miles Prince
Expert Review of Hematology|September 3, 2013
Romidepsin for peripheral T-cell lymphomaAmit Khot, Michael Dickinson, H Miles Prince
Pageof 7